Won Young Park

Won Young Park

Auto-generated profile, based on publicly available information

Won Young Park

Department of Pathology, Seegene Medical Foundation, Busan, Republic of Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

31 January 2020 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
SNSoo Won Nam
Soo Won Nam
YJYeon Joo Jeong
Yeon Joo Jeong
GLGeewon Lee
Geewon Lee
JLJi Won Lee
Ji Won Lee
JEJung Seop Eom
Jung Seop Eom
SPSo Min Park
So Min Park
Inflammatory myofibroblastic tumor is a rare benign lesion that accounts for 0.04–1% of all lung tumors and usually appears as a solitary pulmonary nodule or mass. Here, we report the case of an endobronchial inflammatory myofibroblastic tumor in a 21-year-old man with a focus on the imaging findings and a review of previous literature.

31 March 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TKTae-Yeong Kwak
Tae-Yeong Kwak
CLChan Ho Lee
Chan Ho Lee
WPWon Young Park
Won Young Park
JKJa Yoon Ku
Ja Yoon Ku
CJChang Wook Jeong
Chang Wook Jeong
HHHong Koo Ha
Hong Koo Ha
Prostate cancer (PCa) diagnosis faces significant challenges due to its complex pathological characteristics and insufficient pathologist resources. While deep learning-based image analysis (DLIA) shows promise in enhancing diagnostic accuracy, its application to radical prostatectomy (RP) specimens remains underexplored. In this study, we evaluated the clinical feasibility and prognostic value of a DLIA algorithm for Gleason grading and tumor quantification on whole RP specimens. Using 29,646 digitized H&E-stained slides from 992 patients who underwent RP, we compared the case-level algorithm results with pathologist assessments for the International Society of Urological Pathology grade groups (GG), tumor volumes (TV), and percent tumor volumes (PTV). We also evaluated their prognostic performance in predicting biochemical progression-free survival (BPFS). Pathologists identified cancer in 986 cases and assigned GG in 980, while the DLIA algorithm identified cancer and assigned GG to all cases without omission. DLIA-assigned GG showed fair concordance with pathologist assessments (linear-weighted Cohen’s kappa: 0.374) and demonstrated similar efficacy in predicting BPFS (c-index: 0.644 for DLIA vs. 0.654 for pathologists; p = 0.52). In tumor quantification, DLIA-measured TV and PTV were strongly correlated with pathologist-based measurements (Pearson’s correlation coefficient: 0.830 and 0.846, respectively), but showed stronger efficacy in BPFS prediction, with c-index values of 0.657 and 0.672 compared to 0.622 and 0.641, respectively. Incorporating DLIA-derived PTV into the CAPRA-S score significantly improved its predictive accuracy for BCR (p = 0.006), increasing the c-index from 0.704 to 0.715. Our findings indicate that DLIA algorithms can enhance the accuracy of Gleason grading and tumor quantification in RP specimens, providing valuable support in clinical decision-making for PCa management.

1 January 2022 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Hee-Sung AhnHee-Sung Ahn
Hee-Sung Ahn
JYJeongHun Yeom
JeongHun Yeom
HJHwangkyo Jeong
Hwangkyo Jeong
WPWon Young Park
Won Young Park
JKJa Yoon Ku
Ja Yoon Ku
HHHong Koo Ha
Hong Koo Ha
Ahn HS, et al. World J Mens Health. 2022 Oct;40(4):608-617. https://doi.org/10.5534/wjmh.210165